FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

421949005: Conventional release cutaneous gel (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2617615011 Cutaneous gel en Synonym Active Entire term case insensitive SNOMED CT core module
3541113018 Conventional release cutaneous gel en Synonym Active Entire term case insensitive SNOMED CT core module
3541114012 Conventional release cutaneous gel (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous gel Is a Gel false Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Has basic dose form Gel true Inferred relationship Existential restriction modifier
Conventional release cutaneous gel Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely salicylic acid 60 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 110 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 100 microgram/1 milligram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Metronidazole gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tetracaine hydrochloride 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Clindamycin 1.2%/tretinoin 0.025% topical gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely polynoxylin 100 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 3 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 30 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 100 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 5 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely desoximetasone 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Testosterone 1% gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 1 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Desoximetasone 0.5% gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Testosterone 50mg gel 5g sachet Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Terbinafine hydrochloride 1% gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 400 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely azelaic acid 150 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely dapsone 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely desonide 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ketoconazole 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely oxybutynin hydrochloride 100 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely coal tar 50 milligram/1 gram and pine tar 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely diclofenac diethylammonium 11.6 milligram/1 gram conventional release cutaneous gel Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely estradiol 600 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely testosterone 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely silver nanoparticle 20 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form True Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 100 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 5 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 1 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Conventional release cutaneous gel Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start